Sai Vibrionics Newsletter

A 68-year-old woman was diagnosed with elephantiasis (lymphatic filariasis) six years ago in 2012 after she developed fever, pain, and swelling in both legs and breasts accompanied by fatigue. Whereas swelling progressed gradually over the first 18 months, she experienced recurrent episodes of pain and fever every three months. She received allopathic treatment from the onset, and her entire family was placed on a preventive mass drug administration (MDA) protocol for six years. This helped stop further progression of the disease and arrested the swelling but failed to relieve the cyclical symptoms. Disheartened, she stopped the treatment in 2017 (but the family continued).

In the same year, she developed severe pain in both knees and was diagnosed with filarial arthritis. Since the prescribed medication caused significant acidity and gastric discomfort, she was forced to discontinue it within a year.

While miserable during an episode of fever and leg pain, she consulted the practitioner. She had thickened and darkened skin on her legs; walking was extremely difficult, she used a walker indoors. Social stigma surrounding her condition led her to avoid visitors entirely, she was under considerable emotional distress.

On 17 Dec 2018, she was given:

For elephantiasis:

#1. CC9.3 Tropical diseases + CC12.1 Adult tonic…6TD for three days followed by TDS

For arthritis:

#2. CC15.1 Mental & Emotional tonic + CC18.5 Neuralgia + CC20.3 Arthritis + CC20.4 Muscles & Supportive tissue…6TD for three days followed by TDS and in coconut oil for external application…BD

Treatment Progress:

• 15 Feb 2019: 40% improvement in knee pain, able to move around with limitation; no episodes of fever, pain or fatigue and emotionally more stable.
• 20 June 2019: 70% improvement in knee pain, could walk independently within her home; swelling in legs and breasts reduced by 20%.
• 14 Jan 2020: Complete relief from pain (occasional mild knee pain on overexertion), smooth and normal skin on legs, although no further reduction in swelling; dosage reduced to BD.

As of June 2025, she prefers to continue remedies at BD. Although swelling has plateaued, she finds comfort in massaging the external oil remedy. She walks unaided within her home and has resumed visiting neighbours and attending social gatherings.

Editor’s note: Elephantiasis is considered an incurable disease, only symptoms can be managed; in this case it is heartening vibrionics has freed the patient from pain and immobility and made her life comfortable.